Entity Information
- Legal Entity Identifier (LEI)
- 254900BNZWFX2ZKCBL12
- Registration ID
- 2018260337(ID: RA000073)
- Legal Form
- 8ZH8
- Jurisdiction
Alberta- Legal address country
Canada
Entity Names
Legal Name
Aptalis Pharma Canada ULC(Language: en)
Addresses
Legal Address
Loading map...
Headquarters Address
Loading map...
Additional Information
Entity Status
Current Status
ACTIVENeed to maintain compliance?
LEIs must be renewed annually to keep your entity's information up to date
Renew this LEIReference Guide
LEI status meaning
This LEI is issued, which usually means the registration is active and suitable for current reference and compliance checks.
Renewal date
The next renewal date is May 18, 2027. This is the key deadline for keeping the LEI record current.
Jurisdiction
Aptalis Pharma Canada ULC is registered under jurisdiction CA-AB. Match that jurisdiction with the legal address and local registration number before relying on the LEI.
Parent and ultimate parent
Direct parent is linked to LEI FR5LCKFTG8054YNNRU85, with relationship status active. Ultimate parent is linked to LEI FR5LCKFTG8054YNNRU85, with relationship status active.
How to verify this entity
- •Match the legal name "Aptalis Pharma Canada ULC" to the entity you expect.
- •Check local registration number 2018260337 against authority RA000073.
- •Confirm the validation source RA000073 and reference 2018260337.
Related links
- Sibling entity: บริษัท แอ๊บวี่ ฟาร์มาซูติคอลส์ (ประเทศไทย) จำกัด
- Sibling entity: AbbVie Enterprises B.V.
- Sibling entity: Allergan Pharmaceuticals Ireland Unlimited Company
- Sibling entity: Abbvie Farmaceutica Ltda.
- Direct parent: ABBVIE INC.
- Validate a single LEI
- Check multiple LEIs
- Compare statuses and jurisdictions
LEI Verified Badge
Display your verified LEI status on your website with our free badge widget
Get Your Badge Code
Click "Show Code" to view the HTML code for your LEI Verified badge
Entity & LEI Status Summary
This Legal Entity Identifier (LEI) record pertains to Aptalis Pharma Canada ULC, identified by the LEI 254900BNZWFX2ZKCBL12. The entity is formally registered under the jurisdiction of Alberta (via RA000073, registered as 2018260337) and lists its legal address country as Canada. It operates under the legal structure defined as "8ZH8", classified under the category "GENERAL".
The current operational status of the entity is reported as "ACTIVE". The LEI registration itself is currently "ISSUED", managed by the Local Operating Unit (LOU) 5493001KJTIIGC8Y1R12. Key dates associated with this registration include its initial establishment on Sep 3, 2021, its most recent update on May 18, 2026, and a scheduled renewal date of May 18, 2027.
Maintaining an active and up-to-date LEI is crucial for Aptalis Pharma Canada ULC to ensure continuous participation in global financial markets and regulatory reporting. The corroboration level for this record is "FULLY_CORROBORATED", indicating the extent to which the information has been verified against official registers. The primary validation of this information was performed by RA000073 (as 2018260337).
Registration Details
Timeline
- Initial Registration
- Sep 3, 2021
- Last Updated
- May 18, 2026
- Next Renewal
- May 18, 2027
Validation
Primary Validation
- Authority ID
- RA000073
- Registration Number
- 2018260337
Status Information
Managing Authority
Corporate Structure
Direct Parent
Parent Entity
LEI: FR5LCKFTG8054YNNRU85
Ultimate Parent
Ultimate Parent Entity
LEI: FR5LCKFTG8054YNNRU85
Corporate Structure Visualization
Relationship overview showing parent, sibling, and child entities linked to this LEI.
Child Entities
No child entities found